Novel Drug Combo Improves Function of Cystic Fibrosis Protein - 5/20/15

A novel two-drug combination has the potential to target and restore a defective protein underlying cystic fibrosis (CF), according to two phase III clinical trials conducted at 187 medical centers around the world, including Johns Hopkins.
Source: Johns Hopkins Medicine News - Category: Research Source Type: news